Bempedoic acid: effective tool in the toolkit for LDL-c lowering
Anti-inflammatory therapies for CVD risk prevention
Ulrich Laufs, MD, PhD
Novel PCSK9 inhibitor lowers LDL-c in another large phase 3 study
Evan Stein, MD, PhD
Encouraging data with APOC3 siRNA in mixed hyperlipidemia
Christie Ballantyne, MD
Bempedoic acid safe and effective in non-diabetic patients with metabolic syndrome
Pam R. Taub, MD, FACC, FASPC
Loading...
We’re glad to see you’re enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.